Literature DB >> 16687947

Target blood pressure in patients with end-stage renal disease: evidence-based medicine or the emperor's new clothes?

Thomas G Pickering1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16687947      PMCID： PMC8109417          DOI： 10.1111/j.1524-6175.2005.05123.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  38 in total

1.  Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease.

Authors:  J J De Lima; M L Vieira; H Abensur; E M Krieger
Journal:  Nephrol Dial Transplant       Date:  2001-04       Impact factor: 5.992

2.  Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.

Authors:  Preston S Klassen; Edmund G Lowrie; Donal N Reddan; Elizabeth R DeLong; Joseph A Coladonato; Lynda A Szczech; J Michael Lazarus; William F Owen
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

3.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Giacomina Loriga; Maria Ganeva; Bogdan Ene-Iordache; Marta Turturro; Maria Lesti; Elena Perticucci; Ivan Nediyalkov Chakarski; Daniela Leonardis; Giovanni Garini; Adalberto Sessa; Carlo Basile; Mirella Alpa; Renzo Scanziani; Gianbattista Sorba; Carmine Zoccali; Giuseppe Remuzzi
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

4.  Hypertension in the hemodialysis population: any relation to one-year survival?

Authors:  M M Salem; J Bower
Journal:  Am J Kidney Dis       Date:  1996-11       Impact factor: 8.860

5.  Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study.

Authors:  Robert N Foley; Charles A Herzog; Allan J Collins
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Peter Libby; Paul D Thompson; Magdi Ghali; Dahlia Garza; Lance Berman; Harry Shi; Ethel Buebendorf; Eric J Topol
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

7.  Blood pressure control, drug therapy, and kidney disease.

Authors:  Gabriel Contreras; Tom Greene; Lawrence Y Agodoa; DeAnna Cheek; George Junco; Donna Dowie; James Lash; Michael Lipkowitz; Edgar R Miller; Akinlou Ojo; Mohammed Sika; Beth Wilkening; Robert D Toto
Journal:  Hypertension       Date:  2005-05-16       Impact factor: 10.190

8.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245
View more
  1 in total

1.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.